Gene · 6607
NIH grants1,484
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,221 to 1,240 of 1,484
Download this page as JSON| Grant | Title | SMN2 papers | Newest fiscal year |
|---|---|---|---|
| T15LM007443 | Biomedical Informatics Training Program | 1 | 2012 |
| T32CA009126 | Training Grant in Cancer Biology | 1 | 2012 |
| U01HL102288 | Iowa Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01 | 1 | 2012 |
| R01NS038650 | How low levels of SMN causes Spinal Muscular Atrophy | 24 | 2011 |
| R01HD054599 | Therapeutic Opportunities in Spinal Muscular Atrophy | 22 | 2011 |
| R01HD054413 | Stimulating SMN2 exon 7 inclusion with short RNAs | 20 | 2011 |
| UL1RR025755 | The Ohio State University Center for Clinical and Translational Science (UL1) | 16 | 2011 |
| UL1RR025764 | University of Utah Center for Clinical and Translational Science-UL1 | 12 | 2011 |
| UL1RR024134 | Institutional Clinical and Translational Science Award | 10 | 2011 |
| UL1RR024156 | Clinical and Translational Science Award | 9 | 2011 |
| P20RR020171 | Center for Biomedical Research Excellence in the Molecular Basis of Human Disease | 6 | 2011 |
| UL1RR025005 | Institute for Clinical and Translational Research (UL1) | 5 | 2011 |
| R01HD055835 | Spinal Muscular Atrophy: SMNs role in MRNA localization and local translation | 4 | 2011 |
| P01NS057778 | Stem Cell Therapy and Growth Factor Therapy for ALS | 3 | 2011 |
| P20RR020173 | Center for Pediatric Research | 3 | 2011 |
| R21NS066030 | Spinal Muscular Atrophy: Cell-based drug screens for treatment of axonal defects | 3 | 2011 |
| UL1RR025780 | Colorado Clinical and Translational Science Institute (UL1) | 3 | 2011 |
| KL2RR024980 | University of Iowa Clinical and Translational Science Program (KL2) | 2 | 2011 |
| P20RR016472 | Delaware INBRE | 2 | 2011 |
| P30ES007784 | Mechanisms and Prevention of Environmental Disease | 2 | 2011 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/grants?page=62